Northwestern Mutual Wealth Management
DRNA

Northwestern Mutual Wealth Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-69
Closed – – 2565
2016
Q3 		$0 Buy
+69
New +$242 ﹤0.01% 2378

Other funds holding DRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

Northwestern Mutual Wealth Management's DRNA Position: Q4 2016 in Review

Northwestern Mutual Wealth Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2016, closing a stake of 69 shares.

Northwestern Mutual Wealth Management first reported a position in DRNA in Q3 2016 and held it in 1 quarter. The position peaked at $0 in Q3 2016. 50 funds tracked by Wall St. Rank hold DRNA as of Q4 2016.

  • Northwestern Mutual Wealth Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 69 Dicerna Pharmaceuticals, Inc. shares in Q4 2016.
  • Northwestern Mutual Wealth Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2016 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's Dicerna Pharmaceuticals, Inc. position peaked at $0 in Q3 2016.
  • 50 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2016.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2016, filed 15 Feb 2017.